U.S. Pharmaceutical company improved quality of overall documentation saving time and filing delays
Impact Pharmaceutical Services
SEPTEMBER 20, 2023
Challenge Syner-G was contracted by a US Pharmaceutical Company to help improve the quality of submission documentation generated during the manufacture of a Drug Substance intended for Phase II trials. Results Syner-G reviewed each documentation and provided suggestions/comments/guidance to the CDMO to bridge the gaps observed.
Let's personalize your content